📩 Get the latest developments in clinical supply chain & logistics delivered to your inbox weekly: https://lnkd.in/d6NKbrNt Clinical Supply Leader will help you pinpoint inefficiencies in your supply chain, stay up to date on regulatory changes, identify potential supplier partners, and much more. Join our community today!
Clinical Supply Leader
Internet Publishing
Cranberry Township, Pennsylvania 1,024 followers
A trusted source for those professionals ensuring a secure clinical supply chain from drug development to post-trial.
About us
Clinical Supply Leader is a Life Science Connect community dedicated to facilitating seamless collaboration between key functional roles at the intersection of the clinical trial supply chain and logistics. With a primary focus on clinical operations and supply chain experts, we understand that these disciplines must collaborate to ensure the success of clinical supply management. Our community is committed to being a resource for tailored expertise and valuable insights curated to empower those entrusted with the secure, precise, and punctual delivery of life-saving treatments to patients at their respective clinical sites. We also emphasize the efficient management of product returns, reconciliation, and disposal, ensuring every aspect of the clinical supply chain is addressed securely. From the earliest stages of drug development to the intricacies of post-trial processes we cover all aspects of the clinical supply chain and logistics, from the early stages of drug development to post-trial processes.
- Website
-
https://www.clinicalsupplyleader.com/
External link for Clinical Supply Leader
- Industry
- Internet Publishing
- Company size
- 51-200 employees
- Headquarters
- Cranberry Township, Pennsylvania
- Specialties
- life sciences, clinical supply, clinical supply chain, and clinical supply logistics
Updates
-
The World Health Organization estimates that at least 1 in 10 medicines in low- and middle-income countries are substandard or falsified, resulting in $30.5 billion in annual losses. This highlights the urgent need for more efficient and reliable medical supply chains. As the use of AI and drones grows, these technologies are reshaping the medical supply chain, offering new solutions to long-standing problems. https://lnkd.in/eB9t6xri By Joseph Pategou
-
Looking ahead, the evolution of RTSM in clinical trials points towards cloud-based solutions, heightened emphasis on patient safety, and greater collaboration among stakeholders. Learn how you can prepare: https://lnkd.in/e6Tj22rZ By Ian Davison, RTSM Subject Matter Expert, and Marc Weinberg, Senior Director of RTSM, Medrio
-
The FDA’s draft guidance, published in January, introduces a 7-step framework to ensure AI models used in drug development are robust, reliable, and meet regulatory standards. Fahimeh Mirakhori MSc., Ph.D. reviews the 7 steps: https://lnkd.in/eHXeFFux
-
BEST OF FEBRUARY 🥇 View our top clinical supply chain & logistics insights of the past month: https://lnkd.in/eXBcKBmF Marzena Ingram, ELIQUENT Life Sciences; Dr. Ajay Babu Pazhayattil, cGMP World; Prasanna Sagar, ITAAN PHARMA; Subrata Chakraborty, PhD, INOPHAR Consulting & Training | Signant Health | Purbasa Patnaik, Exelixis | Malcolm Morrissey, Kendra Korte, Perceptive Inc. | Fahimeh Mirakhori MSc., Ph.D.
-
The inherent complexity of living cell-based products, vector-based gene therapies, and highly sensitive analytical methods demands robust change management strategies. This article shares 10 strategies to help accelerate CMC and enable early technology adoption: https://lnkd.in/e8_qskmp By Fahimeh Mirakhori MSc., Ph.D.
-
Many trials fail not because of ineffective treatments, but due to challenges in detecting treatment signals. Explore how advanced data analytics can improve ClinRO quality, ensuring more reliable and accurate clinician ratings in high-stakes clinical research. https://lnkd.in/eVRRbABb Source: Signant Health
-
Manufacturing ADCs is inherently more complex than other biologic drug products. Let's explore some of the key issues, including aggregation, solubility, and thermal instability. https://lnkd.in/eKKP9p4W By Purbasa Patnaik, Exelixis
-
To make the best use of artificial intelligence (AI), drug sponsors need to understand where health authorities are drawing the lines. In the e-book, Citeline shares a sample of their coverage from Asia, Europe and the United States of the emerging framework for artificial intelligence regulation: https://lnkd.in/exsgytun
-
For companies to benefit from outsourcing relationships, there must be an evaluation of the pros and cons that arise from R&D externalization. Here's what you should consider: https://lnkd.in/em5m9Gvd By Will Olughu, Ph.D., Ipsen